• $30.00
    Market Cap
  • 9,900.00%
    1-Year Change
  • Medical Instruments & Supplies
    Industry
Annual
Quarterly
03/31/2021
Income Statement
Total Operating Revenue
18,500
N/A
Cost of Revenue
18,032
N/A
Gross Profit
468
N/A
Sales and Marketing Expense
N/A
N/A
Research and Development Expense
-226,108
N/A
Depreciation and Amortization Expense
24,106
N/A
Total Operating Expenses
14.7M
N/A
Operating Profit
-14.7M
N/A
Interest Income
N/A
N/A
Interest Expense
-47,226
N/A
Interest Income and Expense and Net
-47,226
N/A
Total Nonoperating Income and Expense
1.5M
N/A
Income before Taxes
-16.5M
N/A
Income Taxes
0
N/A
Extraordinary Items
N/A
N/A
Net Income
-16.5M
N/A
Net Income from Continuing Operations Applicable to Common
-16.5M
N/A
Basic EPS and Net Income
6.61
N/A
Diluted EPS and Net Income
6.61
N/A
Basic Weighted Average Shares
305,778
N/A
Diluted Weighted Average Shares
305,778
N/A
Balance Sheet
Cash and Cash Equivalents
0
N/A
Short-Term Investments
N/A
N/A
Cash and Cash Equivalents and Short-Term Investments
0
N/A
Total Current Assets
0
N/A
Accumulated Depreciation
0
N/A
Property and Plant and Equipment and Net
0
N/A
Total Long-Term Assets
0
N/A
Total Assets
0
N/A
Income Taxes Payable
N/A
N/A
Total Short-Term Debt
320,615
N/A
Total Current Liabilities
10.4M
N/A
Total Long-Term Debt
0
N/A
Total Long-Term Liabilities
0
N/A
Total Liabilities
10.4M
N/A
Retained Earnings
-16.5M
N/A
Total Stockholders Equity
-10.4M
N/A
Total Shares Outstanding
305,778
N/A
Cash Flow
Cash from Operating Activities
-467,598
N/A
Capital Expenditures
189,541
N/A
Cash from Investing Activities
-189,541
N/A
Dividends Paid
N/A
N/A
Cash from Financing Activities
657,139
N/A
Financials Ratio
Gross Margin
2.53%
N/A
Operating Margin
-79,505.92%
N/A
Return on Assets
N/A
N/A
Return on Equity
N/A
N/A
Revenue Growth
0.00%
N/A
Current Ratio
0.00
N/A
Cash Ratio
0.00
N/A
Debt-to-Equity Ratio
-0.03
N/A
Debt-to-Assets Ratio
N/A
N/A

Earnings & Revenue History

Debt-to-Assets

Cash Flow